Mitochondrial dysfunction enhances influenza pathogenesis by up-regulating de novo sialic acid biosynthesis
Science Advances · 2025
DOI: 10.1126/sciadv.adu3739 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Amanda L Fuchs und 11 weiteren Autor:innen. Beteiligte Einrichtung: Metabolism, Infection, and Immunity Section, Metabolic Medicine Branch, National Human Genome Research Institute, National Institutes of Health, Beth…. Hauptthemen laut MEDLINE: Mitochondria, N-Acetylneuraminic Acid, Influenza A virus, Orthomyxoviridae Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.
Abstract (Originalsprache)
Mitochondrial dysfunction can trigger metabolic adaptations that resemble those induced by influenza A virus (IAV) infection. Here, we show that oxidative phosphorylation (OXPHOS) impairment, modeled by Ndufs4 deficiency, reprograms lung epithelial metabolism to promote IAV pathogenesis. In both Ndufs4 knockout (KO) mice and lung epithelial cells, OXPHOS deficiency increased glycolytic flux, diverting carbons into hexosamine and de novo sialic acid (SIA) biosynthesis pathways. This led to elevated sialylation and enhanced viral attachment. In Ndufs4 KO models, adenosine monophosphate–activated protein kinase signaling was insufficient to blunt this increased metabolic flux. IAV infection further exacerbated this metabolic vulnerability, amplifying SIA and viral burden. Pharmacologic rerouting of glucose carbons with dichloroacetate reduced sialylation, viral replication, and inflammatory responses in Ndufs4 KO models. These findings reveal that mitochondrial dysfunction enhances IAV susceptibility by disrupting energy sensing and fueling viral receptor biosynthesis, highlighting the importance of epithelial metabolism in viral pathogenesis and suggesting metabolic modulation as a potential therapeutic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Metabolism, Infection, and Immunity Section, Metabolic Medicine Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
- Division of Veterinary Resources, Office of Research Services, National Institutes of Health, Bethesda, MD, USA.
- Cellular Biology Section, National Institute of Allergy and Infectious, National Institutes of Health, Bethesda, MD, USA.
ORCID-Profile: Amanda L Fuchs, Bharati Singh, Jillian W Jetmore, Emily B Warren, Payal Banerjee, Tatiana N Tarasenko, Madeleine R Assaad, Ivan Kosik, Jonathan Yewdell, Peter J McGuire
Förderung
- Intramural NIH HHS
Zitieren
APA
Fuchs, A. L., Singh, B., Jetmore, J. W., Warren, E. B., Banerjee, P., Marin Franco, J. L., Eckhaus, M. A., Tarasenko, T. N., Assaad, M. R., Kosik, I., Yewdell, J., & McGuire, P. J. (2025). Mitochondrial dysfunction enhances influenza pathogenesis by up-regulating de novo sialic acid biosynthesis. Science Advances. https://doi.org/10.1126/sciadv.adu3739
Vancouver
Fuchs AL, Singh B, Jetmore JW, Warren EB, Banerjee P, Marin Franco JL, et al. Mitochondrial dysfunction enhances influenza pathogenesis by up-regulating de novo sialic acid biosynthesis. Science Advances. 2025. doi:10.1126/sciadv.adu3739
BibTeX
@article{Fuchs2025,
author = {Fuchs, Amanda L and Singh, Bharati and Jetmore, Jillian W and Warren, Emily B and Banerjee, Payal and Marin Franco, Jose L and Eckhaus, Michael A and Tarasenko, Tatiana N and Assaad, Madeleine R and Kosik, Ivan and Yewdell, Jonathan and McGuire, Peter J},
title = {Mitochondrial dysfunction enhances influenza pathogenesis by up-regulating de novo sialic acid biosynthesis},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adu3739}
}
EUVIMED